Laguilles, Aldwin C.

HRN: 21-32-86  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/12/2022
05/19/2022
IV
600mg
Q8H
Nasal Abscess
Waiting Final Action 
05/12/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/12/2022
05/19/2022
IV
1.5g
Q6H
Nasal Abscess
Waiting Final Action 
05/14/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/14/2022
05/20/2022
TOPICAL
25gm
BID
Infected Wound Nasal Area
Waiting Final Action 
05/15/2022
CLINDAMYCIN 300MG (CAP)
05/15/2022
05/18/2022
PO
300mg
QID
Nasal Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: